Coronavirus company news summary – Genesprint Group and Infrawear introduce Covid-19 swab test in EU – Imec to develop SARS-CoV-2 test based on exhaled breath

26 October 2020 (Last Updated October 26th, 2020 09:38)

Celltrion, a biopharmaceutical company, has received emergency approval from the US Food and Drug Administration (FDA) for its Covid-19 antigen diagnosis kit Sampinute. The testing kit uses a proprietary antibody-antigen technology, which delivers results in less than 10 minutes. Compared to existing RT-PCR tests, the Sampinute kit can deliver results with 94% accuracy.

Genesprint Group, a testing company, and Infrawear, testing and antibody kits provider, announced plans to introduce rapid antigen throat and mouth swab test for Covid-19 in the Europe. The test is CE marked and can deliver results in right minutes with 99.99% specificity.

Imec, a research and innovation hub, has commenced the development of a new test capable of detecting SARS-CoV-2 virus through a person’s exhaled breath. The test can deliver accurate results in less than five minutes. A prototype of the test is expected to be available for testing in 2021.